Skip to content

SCHEDULE 13GAccepted May 29, 4:48 PM ET

BridgeBio Pharma, Inc. SCHEDULE 13G

Farallon Capital Partners, L.P.

Accepted (ET)

4:48 PM

May 29, 2026

Filed

May 29, 2026

Documents

2

Size

56.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.